Nerve Health · Bromelain & Nerve Inflammation

Bromelain for Nerve Pain and Neuropathy: What the Science Shows

A pineapple enzyme with a serious anti-inflammatory mechanism, reviewed by the nerve surgeon who published on it.

Editorial cross-section of a peripheral nerve showing axons, myelin, and fascicular structure. The tissue surrounding those fascicles is where bromelain acts.

Most people searching for bromelain for nerve pain are quietly hoping for one thing: something that works as well as their prescription, without the fog, the dizziness, and the unsteady gait. That hope is reasonable. It is also where the internet tends to oversell, so let us be precise from the first sentence.

I am a fellowship-trained peripheral nerve surgeon, and in 2023 I published a peer-reviewed review titled Bromelain as a Therapeutic Option for Treatment of Neuropathic Pain in Acta Scientific Orthopaedics. So when I write about bromelain for neuropathy, I am writing from inside the literature rather than summarizing someone else's blog post. That also means I know exactly where the evidence is strong and where it runs out.

Bromelain is a complex of cysteine proteases (protein-digesting enzymes) extracted from the pineapple plant (Ananas comosus). Its highest concentration sits in the tough, inedible stem, which is why a standardized supplement, not a fruit salad, is the only realistic way to reach the doses used in research. Beyond digesting protein, bromelain influences several inflammatory pathways that nerve scientists care about a great deal.

Bromelain for Nerve Pain: The Honest Answer

If you asked me this across an exam room table, here is what I would say.

Bromelain is not a proven treatment for neuropathy. No large, standalone, placebo-controlled human trial has tested it that way, and anyone telling you it is “clinically proven” for nerve damage is overstating what exists. I would rather lose the sale than tell you otherwise.

What bromelain does have is a well-characterized anti-inflammatory mechanism that maps directly onto the biology of an irritated, compressed, or inflamed peripheral nerve, plus a body of animal work in nerve-constriction injury that is more consistent than most people realize, plus human data from formulas that contain it. That distinction, between a real mechanism with supporting preclinical evidence and a finished clinical verdict, is the entire point of this article. If you understand it, you will make a better decision than most people shopping for nerve support.

The place I am most comfortable with bromelain is where its mechanism and my surgical experience overlap: compression neuropathies, where swelling inside a closed tunnel is a meaningful part of the problem. The place I am least comfortable is anyone using it as a reason to skip a diagnosis.

What Is Bromelain, and What Does It Actually Do?

Bromelain is not a single molecule. It is a mixture of proteolytic enzymes, along with several minor non-enzyme compounds, harvested mostly from the stem of the pineapple plant. Commercial stem bromelain is a byproduct of the pineapple industry, which is part of why it is inexpensive relative to how much biology it touches.

Its behavior depends on when you take it, which is a detail most articles skip:

Taken with food, bromelain works as a digestive enzyme, helping break dietary protein into smaller peptides. This is the traditional use and the one most people associate with pineapple.

Taken between meals, a meaningful fraction is absorbed intact into circulation, where it stops being a digestive aid and starts behaving as an immune modulator. This is the mode that matters for nerve pain and inflammation, and it is why enteric coating and dosing away from food come up repeatedly in the research literature.

Once it is circulating, bromelain does three broad things to the tissue environment. It lowers inflammatory signaling, reducing cytokines such as IL-6 and TNF-alpha. It reduces swelling, by breaking down fibrin and supporting the body's own fibrin-clearing machinery. And it clears pain-amplifying chemicals, most notably by degrading the precursor protein the body uses to manufacture bradykinin. Those three effects are the whole story of why anyone studies bromelain in nerve tissue at all.

Nerve Pain Is an Inflammation Story

When a peripheral nerve is compressed, ligated, or metabolically stressed, the tissue does not simply hurt. It mounts a biochemical inflammatory response, and that response is a large part of why the pain becomes loud and persistent.

Here is the short version of the biology. Injured nerves switch on an enzyme called cyclooxygenase-2, or COX-2, the same enzyme that ibuprofen and aspirin target. COX-2 produces prostaglandin E2 (PGE2), a chemical that makes pain-sensing nerve endings far more sensitive than they should be. Sitting one level above COX-2 is a master switch called nuclear factor-kappa B, or NF-κB. Think of NF-κB as the main breaker that turns on the body's entire inflammation circuit at once: COX-2, plus several other inflammation-driving genes, plus the inflammatory messenger molecules (cytokines) that keep the fire going. When NF-κB stays switched on for too long, an injured nerve stays in a sensitized, painful state.

This is the part the operating room makes vivid. A nerve trapped in a tight tunnel is not just mechanically squeezed. The surrounding tissue is swollen, fibrotic, and chemically inflamed. Relieving the inflammation matters alongside relieving the pressure. That is precisely the biology bromelain has been studied against.

How Bromelain Works on Nerve Tissue

Bromelain is unusual because it is not a single-target compound. It influences several overlapping anti-inflammatory cascades at once, which is why researchers describe it as an immune modulator (a tuner) rather than a simple suppressant (an off-switch).

1. It dials down the master inflammation switch. Bromelain inhibits activation of NF-κB, which in turn quiets the downstream production of COX-2, other inflammation-driving enzymes, and inflammatory messenger molecules. A 2024 review in Nutrients catalogued this effect across immune cell studies, where bromelain suppressed NF-κB signaling and reduced two of the most aggressive inflammatory messengers, IL-6 and TNF-alpha.

2. It reduces the same pain-sensitizing chemical that ibuprofen targets. By inhibiting COX-2 expression, bromelain reduces synthesis of prostaglandin E2, the chemical that turns up the volume on pain signals. That is the same target as common anti-inflammatory drugs, reached through a different route.

3. It clears out a separate pain chemical called bradykinin. Here bromelain's protein-digesting nature becomes an asset. Bradykinin is one of the most powerful pain-amplifying chemicals the body produces. Bromelain breaks down kininogen, the precursor protein the body uses to manufacture bradykinin, so less bradykinin gets made in the first place. Less bradykinin means less pain signaling.

4. It supports the nerve's own antioxidant defenses. In nerve-injury models, bromelain normalized NRF1 and NRF2, the regulatory factors that switch on a cell's antioxidant enzyme program. This matters because oxidative stress is a shared final pathway in both compressive and diabetic nerve injury.

5. It blunts a damage pathway specific to diabetes. The 2024 review also documented bromelain's effect on a pathway called AGE-RAGE. In plain language: when blood sugar runs high for long periods, sugar molecules stick to proteins throughout the body, forming damaged proteins called advanced glycation end-products (AGEs). These bind a receptor called RAGE, and that binding sets off chronic inflammation. The AGE-RAGE pathway is a recognized driver of diabetic nerve damage, which makes bromelain's effect on it especially relevant to anyone whose nerve symptoms trace back to blood sugar.

One honest caveat belongs right here. The bulk of this mechanistic detail comes from preclinical work, meaning cell cultures and animal models. The pathways are real and well-mapped, but a documented mechanism is a reason for scientific interest, not a guarantee of a clinical result in humans.

Bromelain acts on multiple inflammatory pathways: NF-κB, COX-2/PGE2, and the bradykinin precursor kininogen.

A Mechanical Bonus: Edema and Compressed Nerves

For compression conditions specifically, meaning carpal tunnel, cubital tunnel, and tarsal tunnel, bromelain offers a second, more physical line of action. Its protein-digesting activity breaks down fibrin (a sticky protein that builds scaffolding in swollen, inflamed tissue) and supports fibrinolysis (the body's natural process for clearing those fibrin deposits).

The practical translation: bromelain has been shown in preclinical work to reduce interstitial edema, the fluid accumulation in tissue that crowds a nerve inside an already tight compartment. In a space-limited tunnel, less swelling means less mechanical pressure on the nerve. Bromelain also supports microcirculation, the small-vessel blood flow that is compromised in both compressive and diabetic neuropathy. None of this repairs a damaged nerve, but it addresses the environment the nerve has to live in.

There is one more finding from the animal literature worth naming, because it surprised me. Bakare and Owoyele reported that bromelain reversed the electrolyte imbalance found inside chronically constricted sciatic nerve tissue. Sodium and potassium handling is not a side issue for a nerve. It is the physical basis of how a nerve fires. Restoring it, at least in a rodent model, is a more fundamental effect than simply quieting pain behavior.

Is Pineapple Good for Neuropathy?

This question deserves a straight answer, because it is one of the most common ways people arrive at this topic, and because the internet answers it badly in both directions.

Pineapple is a perfectly reasonable food. It is not a nerve therapy. Three things stand between a bowl of pineapple and a research-level bromelain dose.

First, location. Bromelain is concentrated in the stem and, to a lesser extent, the fibrous core. The sweet flesh you actually eat contains comparatively little. Commercial supplements are made from the stem precisely because that is where the enzyme lives.

Second, heat. Bromelain is a protein, and proteins denature. Canned pineapple has been heat-treated, and pasteurized pineapple juice has too, which inactivates much of the enzyme. If bromelain is the reason you are eating pineapple, canned fruit and shelf-stable juice contribute close to nothing.

Third, digestion. Whatever active enzyme survives to your stomach then meets gastric acid, which degrades a substantial portion before absorption. This is exactly why anti-inflammatory bromelain research uses enteric-coated preparations taken away from food.

Put the numbers side by side and the gap is obvious. Research protocols work in the range of several hundred to a couple thousand GDU of enzyme activity per day, delivered in a protected form. A generous serving of fresh pineapple delivers a small fraction of that, most of it destroyed before it ever reaches circulation.

There is also a consideration people rarely raise. Pineapple carries a real sugar load, and a large portion can move blood glucose noticeably. If your neuropathy is metabolic in origin, eating a lot of pineapple to chase a trace amount of bromelain is working against yourself. A cup of fresh pineapple as part of an otherwise nerve-supportive diet is fine. Treating it as your neuropathy strategy is not.

What the Research Shows on Bromelain and Pain

Before we get to nerves specifically, it is worth knowing what bromelain's broader pain literature actually looks like, because plenty of people arrive here searching for joint pain, tendon pain, or back pain rather than neuropathy.

Swelling after surgery and injury is where the evidence is strongest. Bromelain has been studied for decades in post-surgical and post-traumatic edema, particularly in dental and oral surgery, and this is the setting where its fibrin-clearing and anti-edema effects show up most consistently. If you see bromelain in a recovery formula, that is the tradition it comes from.

Knee osteoarthritis is genuinely mixed. An open study in otherwise healthy adults with mild acute knee pain found dose-dependent improvement in pain and well-being over a month. But a randomized placebo-controlled pilot in moderate-to-severe knee osteoarthritis found no advantage over placebo. Read together, those results suggest bromelain may do more for mild, inflammation-dominant pain than for advanced structural joint disease. That is a useful lesson for nerve pain too.

Tendonitis and back pain are extrapolation, not evidence. I want to be direct here, because a lot of supplement content is not. There are no strong randomized trials of bromelain for tendinopathy or for low back pain. What exists is a plausible anti-inflammatory rationale plus a favorable safety profile. That is a reason someone might study it. It is not a reason to claim it works.

Systematic reviews of inflammatory markers are inconsistent. When researchers pool the clinical trials that measured CRP, IL-6, and TNF-alpha after bromelain supplementation, the results do not line up neatly. Doses, formulations, populations, and durations all differ. This is the unglamorous reality of nutraceutical research, and it is why I am careful about the verbs I use.

My Published Research on Bromelain and Neuropathic Pain

In 2023 I published “Bromelain as a Therapeutic Option for Treatment of Neuropathic Pain” in Acta Scientific Orthopaedics (2023;6(10):83-85). It is a mini review, not a clinical trial, and I want to describe it accurately rather than inflate it.

Why I wrote it. I spend my professional life with patients whose nerves hurt, and the pharmacologic options are thin. The Cochrane review of gabapentin for neuropathic pain, covering 37 randomized trials and more than 5,600 participants, found that roughly 1 in 6 people with diabetic neuropathy reach meaningful pain relief, while over 60 percent experience at least one adverse event, most commonly dizziness, drowsiness, and unsteadiness. When your best-studied drug performs like that, looking harder at low-risk alternatives is not fringe thinking. It is due diligence.

What the review covered. I traced the chain from nerve injury to pain: injured nerves upregulate COX-2, PGE2 rises, and NF-κB sits upstream regulating neuronal COX-2 gene expression. Then I assembled the bromelain evidence against that chain. Bromelain inhibits COX-2 expression by blocking MAPK-regulated NF-κB activation. In rodent nerve-constriction and sciatic-ligation models, bromelain produced antinociceptive and anti-anxiety effects alongside reductions in pro-inflammatory mediators, normalized NRF1 and NRF2 antioxidant signaling, and reversed the electrolyte imbalance in the constricted nerve. In one of those studies, treated nerve structure appeared comparable to animals that had never been injured.

What I concluded. That bromelain represents a therapeutic option worth serious investigation for neuropathic pain, and that in the preclinical comparisons available it appeared to offer anti-inflammatory effects at least as strong as gabapentin, with a far lighter side-effect burden.

What that conclusion does not mean. Here is the caveat I insisted on then and insist on now: the gabapentin comparison rests on animal models. There is no published head-to-head human trial of bromelain against gabapentin. A rodent chronic-constriction model is a good model of neuropathic pain, and it is still a rodent. Nobody should read my review and stop a prescription. The honest framing is not “bromelain beats gabapentin.” It is that gabapentin is a useful drug for some people and a disappointment for many, with a real side-effect load, and that a well-tolerated, mechanism-driven nutritional approach deserves proper human study.

My clinical data: bromelain in a formula around carpal tunnel surgery

My review also drew on my own surgical outcomes work. In Modern Plastic Surgery (2022;12:13-24) I reported on 64 patients undergoing endoscopic carpal tunnel release. Eighteen took a multi-ingredient nerve support formula containing bromelain (alongside methylcobalamin, acetyl-L-carnitine, N-acetylcysteine, benfotiamine, R-alpha-lipoic acid, curcumin, serrapeptase, and vitamins D and B6), beginning five days before surgery and continuing for three weeks after. Forty-six served as controls.

At the two-week follow-up, the supplemented group showed greater improvement on the Boston Carpal Tunnel Questionnaire in both symptom severity (a 1.51-point change versus 0.98 in controls) and function (0.98 versus 0.38). An earlier report from the same line of work found reduced pillar pain and fewer patients requiring pain medication after the procedure.

Now the disclosures, because they matter. That study was not randomized or blinded, the group sizes were uneven, the formula was multi-ingredient so bromelain's individual contribution cannot be isolated, and I have a commercial interest in nerve support formulation. I am telling you the result and the limitations in the same breath because that is the only way a finding like this is worth anything to you.

What the Human Evidence Actually Says

Here is the most important paragraph in this article. A thorough search of the medical literature finds no standalone, placebo-controlled human trial of bromelain by itself for neuropathic pain. Anyone claiming bromelain is clinically proven to treat neuropathy is overstating what exists.

What we do have is human data on bromelain inside multi-ingredient formulas, and it is more interesting than nothing.

The most relevant is a 2020 controlled trial in early carpal tunnel syndrome. One group received physical therapy alone; the other added an oral formula containing bromelain alongside acetyl-L-carnitine, alpha-lipoic acid, quercetin, and B vitamins. The combination group showed statistically significant improvements in sensory nerve conduction velocity (an objective electrical measurement of how fast sensory nerve signals travel, used to track nerve recovery) and in sleep quality, at both 30 and 60 days.

A second line of human work comes from oncology. A prospective study in chemotherapy-induced peripheral neuropathy followed 25 patients on a supplement combining alpha-lipoic acid, methylsulfonylmethane, and bromelain. After 12 weeks, both pain scores and sensory and motor neuropathy scores had improved, in a population where treatment options are famously limited. Again: small, multi-ingredient, not placebo-controlled, and bromelain's individual share cannot be separated out.

That pattern is not a flaw in the science so much as a reflection of how nerve-support nutrition is actually designed and used, as synergistic combinations rather than single compounds. It does mean the honest phrase is “formulas containing bromelain have shown” rather than “bromelain has been shown.”

How Bromelain Is Used: Dosage, GDU, and Forms

This section is research context, not a personal dosing recommendation. What follows is what studies have used and how to read a label, so you can have an informed conversation with your own clinician.

The range studied. Human research on bromelain has generally worked in the range of roughly 200 to 2,000 mg per day, usually divided into two or three doses. Anti-inflammatory protocols cluster toward the higher end of that range and dose away from food; digestive-enzyme use clusters lower and doses with meals.

Why milligrams are the wrong unit. This is the single most useful thing in this article for anyone comparing products. Milligrams measure mass, not enzyme activity. Two capsules both labeled “500 mg bromelain” can differ several-fold in how much actual proteolytic work they can perform. Activity is expressed in GDU (gelatin dissolving units) or MCU (milk clotting units), where 1 GDU is roughly 1.5 MCU. A label that gives you milligrams and nothing else is not giving you enough information to compare anything.

For reference, the bromelain content in our own NeuroAxis formula is specified at 600 GDU, precisely so the activity is stated rather than implied.

Enteric coating and timing. Because bromelain is a protein that gastric acid degrades, anti-inflammatory research favors enteric-coated preparations that dissolve in the small intestine rather than the stomach. Taking it between meals, rather than with food, keeps it from being consumed digesting your lunch. If you are taking bromelain for digestive support instead, the opposite applies.

Safety, Allergies, and Drug Interactions

Bromelain has a favorable safety profile across the doses studied, and standard supplemental ranges have been used for prolonged periods without major adverse events. Mild, dose-related side effects can include nausea, diarrhea, or abdominal discomfort. But natural does not mean free of interactions, and a few points genuinely matter.

Pineapple allergy is a direct contraindication. There is also documented cross-reactivity with latex and with allergens such as ragweed, grass pollen, celery, and wheat. If you react to any of those, this is a conversation to have before you start, not after.

Blood thinners require caution. Bromelain has mild blood-thinning and clot-breaking activity, so it can amplify the effect of anticoagulants such as warfarin and antiplatelet drugs such as aspirin and clopidogrel. If you take any of these, this is a conversation with your physician, not a solo decision.

Stop before surgery. Because of those same blood-thinning effects, bromelain should be discontinued at least two weeks before any scheduled procedure. I say this as the surgeon on the other side of that operation. It can also enhance absorption of certain antibiotics, including amoxicillin and tetracyclines, which is occasionally useful and occasionally a problem.

Pregnancy and breastfeeding. There is not enough safety data to support use, so the appropriate answer is to avoid it unless your physician says otherwise.

How Bromelain Fits Into Nerve Support

Bromelain's strongest role is almost certainly as one component of a multi-pathway approach, and the reasoning is mechanistic rather than promotional.

Think of nerve support as two separate jobs. One is the tissue environment: the inflammation, swelling, fibrin, and impaired microcirculation surrounding a stressed nerve. The other is nerve metabolism: the myelin maintenance, mitochondrial energy production, and antioxidant defense happening inside the nerve itself. Bromelain works almost entirely on the first job. It does not build myelin and it does not fuel an axon.

That is why it appears in formulas alongside ingredients that work on the second job. Methylcobalamin, the active form of B12, supports the methylation chemistry that maintains the myelin sheath. R-alpha-lipoic acid addresses oxidative stress, with the strongest trial evidence of any nerve nutrient. Benfotiamine, a fat-soluble form of B1, targets the glucose-driven damage pathways. Acetyl-L-carnitine supports mitochondrial energy production in the nerve. Bromelain also has documented synergy with curcumin, meaningfully increasing curcumin's otherwise poor oral absorption while the two suppress overlapping inflammatory pathways from different upstream directions.

If you want the ingredient-by-ingredient breakdown of which of these actually have human trial evidence and which do not, I wrote a full evidence review of nerve supplements. And if compression is your specific situation, the carpal tunnel supplement guide goes deeper on that case.

A Sensible Path Forward

Frequently Asked Questions

Is pineapple good for neuropathy?

Pineapple is a reasonable food in a nerve-supportive diet, but eating it is not a way to get a research-level bromelain dose. The enzyme is concentrated in the tough stem and core rather than the sweet flesh, canning and pasteurization inactivate much of it, and stomach acid degrades more of what survives. Pineapple also carries a meaningful sugar load, which matters if blood sugar is part of your nerve picture. Enjoy it as fruit, not as therapy.

Does bromelain help nerve pain?

Bromelain has a well-documented anti-inflammatory mechanism relevant to irritated nerve tissue, animal models of nerve constriction injury show consistent antinociceptive effects, and human data from multi-ingredient formulas is encouraging. No standalone, placebo-controlled human trial has tested bromelain by itself for neuropathic pain. The honest answer: mechanistically well supported, not clinically proven on its own.

How much bromelain is used in studies?

Research has examined roughly 200 to 2,000 mg per day, usually divided across two or three doses, with anti-inflammatory protocols clustering toward the higher end and dosing away from food. Milligrams alone are misleading, because they measure mass rather than enzyme activity. Potency is expressed in GDU (gelatin dissolving units) or MCU (milk clotting units). This is research context, not a dosing recommendation; discuss a specific dose with a knowledgeable healthcare provider.

Is bromelain safe, and who should avoid it?

Bromelain has a favorable safety profile across the doses studied, with mild dose-related side effects such as nausea, diarrhea, or abdominal discomfort. Anyone with a pineapple allergy should avoid it, and cross-reactivity with latex, ragweed, grass pollen, celery, and wheat is documented. Because bromelain has mild blood-thinning activity, anyone taking warfarin, aspirin, clopidogrel, or another anticoagulant or antiplatelet drug should speak with their physician first. Stop it at least two weeks before any scheduled surgery, and avoid it in pregnancy and breastfeeding unless your doctor advises otherwise.

What does bromelain do in the body?

Bromelain is a group of protein-digesting (proteolytic) enzymes from the pineapple plant. Taken with food, it helps break down dietary protein. Taken between meals, a portion is absorbed intact and acts on the tissue environment: it dampens NF-κB signaling and COX-2 expression, lowers inflammatory messengers such as IL-6 and TNF-alpha, breaks down the bradykinin precursor kininogen, and supports fibrin breakdown, which is part of how it reduces swelling.

Does bromelain help joint pain, tendonitis, or back pain?

The strongest human evidence for bromelain is in post-surgical and post-traumatic swelling. For knee osteoarthritis the results are mixed: an open study in mild acute knee pain found dose-dependent improvement, while a placebo-controlled pilot in moderate-to-severe knee osteoarthritis found no advantage over placebo. For tendonitis and back pain specifically there are no strong randomized trials, so any claim rests on the general anti-inflammatory mechanism rather than direct evidence.

Is bromelain better than gabapentin?

No human study has compared them directly, including my own published review, which drew on rodent nerve-injury models. In those models bromelain matched or exceeded gabapentin's effect on pain behavior and inflammatory markers. Gabapentin's own human data shows modest response rates and frequent side effects, but that is not the same as proof that bromelain is superior in people. Never change a prescription without your doctor.

Is bromelain good for carpal tunnel?

Compression neuropathy is bromelain's best-supported nerve application. A 2020 controlled trial found that a multi-ingredient oral formula containing bromelain improved sensory nerve conduction and sleep quality in early carpal tunnel syndrome, and my own published data on a bromelain-containing formula used around endoscopic carpal tunnel release showed better early symptom and function scores. Its swelling-reducing, fibrin-clearing action is a logical fit for a nerve trapped in a tight tunnel.

This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation, particularly before starting any supplement if you take prescription medication.